Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Frick

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Drug News & Perspectives|September 16, 2003
Helicases as antiviral drug targetsDavid N Frick
Hepatology (Baltimore, Md.)|May 27, 2006
Step-by-step progress toward understanding the hepatitis C virus RNA helicaseDavid N Frick
Current Issues in Molecular Biology|February 1, 2007
The hepatitis C virus NS3 protein: a model RNA helicase and potential drug targetDavid N Frick
Analytical Biochemistry|February 16, 2020
Fluorescent probe displacement assays reveal unique nucleic acid binding properties of human nudix enzymesAtreyei Ray, David N Frick
Biotechniques|October 16, 2008
Monitoring helicase activity with molecular beaconsCraig A Belon, David N Frick
Future Virology|February 18, 2010
Helicase inhibitors as specifically targeted antiviral therapy for hepatitis CCraig A Belon, David N Frick
Journal of Molecular Biology|April 1, 2009
Fuel specificity of the hepatitis C virus NS3 helicaseCraig A Belon, David N Frick
Journal of Virology|December 15, 2005
Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicaseAngela M I Lam, David N Frick
Advances in Experimental Medicine and Biology|November 25, 2018
New Techniques to Study Intracellular Receptors in Living Cells: Insights Into RIG-I-Like Receptor SignalingM J Corby, Valerica Raicu, David N Frick
Biochemical Pharmacology|January 29, 2009
Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymeraseJulie A Heck, Xiao Meng, David N Frick
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Drug News & Perspectives|September 16, 2003
Helicases as antiviral drug targetsDavid N Frick
Hepatology (Baltimore, Md.)|May 27, 2006
Step-by-step progress toward understanding the hepatitis C virus RNA helicaseDavid N Frick
Current Issues in Molecular Biology|February 1, 2007
The hepatitis C virus NS3 protein: a model RNA helicase and potential drug targetDavid N Frick
Analytical Biochemistry|February 16, 2020
Fluorescent probe displacement assays reveal unique nucleic acid binding properties of human nudix enzymesAtreyei Ray, David N Frick
Biotechniques|October 16, 2008
Monitoring helicase activity with molecular beaconsCraig A Belon, David N Frick
Future Virology|February 18, 2010
Helicase inhibitors as specifically targeted antiviral therapy for hepatitis CCraig A Belon, David N Frick
Journal of Molecular Biology|April 1, 2009
Fuel specificity of the hepatitis C virus NS3 helicaseCraig A Belon, David N Frick
Journal of Virology|December 15, 2005
Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicaseAngela M I Lam, David N Frick
Advances in Experimental Medicine and Biology|November 25, 2018
New Techniques to Study Intracellular Receptors in Living Cells: Insights Into RIG-I-Like Receptor SignalingM J Corby, Valerica Raicu, David N Frick
Biochemical Pharmacology|January 29, 2009
Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymeraseJulie A Heck, Xiao Meng, David N Frick
Pageof 6